Literature DB >> 23417379

Double trouble in a patient with myotonia.

Michael K Hehir1, Eric Logigian, Dipa L Raja Rayan, Emma Ciafaloni.   

Abstract

Non-dystrophic myotonias (NDM) are characterised by muscle stiffness during voluntary movement owing to delayed skeletal muscle relaxation caused by mutations in the chloride (CLCN1) and sodium (SCN4A) skeletal muscle channel genes. Late onset acid maltase deficiency (AMD) is characterised by progressive respiratory and proximal muscle weakness; electrical but not clinical myotonia can be observed. Case report of a unique patient with concurrent NDM and AMD. We describe the clinical presentation and management of a patient with two rare neuromuscular disorders. This case illustrates the importance of reopening the differential diagnosis in patients who do not conform to the typical natural history of a specific disease.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23417379      PMCID: PMC3604294          DOI: 10.1136/bcr-2012-008167

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  14 in total

1.  Muscle MRI in adult-onset acid maltase deficiency.

Authors:  Anna Pichiecchio; Carla Uggetti; Sabrina Ravaglia; Maria Grazia Egitto; Miriam Rossi; Giorgio Sandrini; Cesare Danesino
Journal:  Neuromuscul Disord       Date:  2004-01       Impact factor: 4.296

2.  A randomized study of alglucosidase alfa in late-onset Pompe's disease.

Authors:  Ans T van der Ploeg; Paula R Clemens; Deyanira Corzo; Diana M Escolar; Julaine Florence; Geert Jan Groeneveld; Serge Herson; Priya S Kishnani; Pascal Laforet; Stephen L Lake; Dale J Lange; Robert T Leshner; Jill E Mayhew; Claire Morgan; Kenkichi Nozaki; Dorothy J Park; Alan Pestronk; Barry Rosenbloom; Alison Skrinar; Carine I van Capelle; Nadine A van der Beek; Melissa Wasserstein; Sasa A Zivkovic
Journal:  N Engl J Med       Date:  2010-04-15       Impact factor: 91.245

3.  Electromyography guides toward subgroups of mutations in muscle channelopathies.

Authors:  Emmanuel Fournier; Marianne Arzel; Damien Sternberg; Savine Vicart; Pascal Laforet; Bruno Eymard; Jean-Claude Willer; Nacira Tabti; Bertrand Fontaine
Journal:  Ann Neurol       Date:  2004-11       Impact factor: 10.422

Review 4.  Muscle channelopathies.

Authors:  David S Saperstein
Journal:  Semin Neurol       Date:  2008-04       Impact factor: 3.420

5.  Morphological changes in muscle tissue of patients with infantile Pompe's disease receiving enzyme replacement therapy.

Authors:  Léon P F Winkel; Joep H J Kamphoven; Hannerieke J M P van den Hout; Lies A Severijnen; Pieter A van Doorn; Arnold J J Reuser; Ans T van der Ploeg
Journal:  Muscle Nerve       Date:  2003-06       Impact factor: 3.217

Review 6.  Pompe's disease.

Authors:  Ans T van der Ploeg; Arnold J J Reuser
Journal:  Lancet       Date:  2008-10-11       Impact factor: 79.321

7.  Late onset Pompe disease: clinical and neurophysiological spectrum of 38 patients including long-term follow-up in 18 patients.

Authors:  Wolfgang Müller-Felber; Rita Horvath; Klaus Gempel; Teodor Podskarbi; Yoon Shin; Dieter Pongratz; Maggie C Walter; Martina Baethmann; Beate Schlotter-Weigel; Hanns Lochmüller; Benedikt Schoser
Journal:  Neuromuscul Disord       Date:  2007-07-23       Impact factor: 4.296

8.  Whole-body high-field MRI shows no skeletal muscle degeneration in young patients with recessive myotonia congenita.

Authors:  C Kornblum; G G Lutterbey; B Czermin; J Reimann; J-C von Kleist-Retzow; K Jurkat-Rott; M P Wattjes
Journal:  Acta Neurol Scand       Date:  2009-12-28       Impact factor: 3.209

Review 9.  The non-dystrophic myotonias: molecular pathogenesis, diagnosis and treatment.

Authors:  E Matthews; D Fialho; S V Tan; S L Venance; S C Cannon; D Sternberg; B Fontaine; A A Amato; R J Barohn; R C Griggs; M G Hanna
Journal:  Brain       Date:  2009-11-16       Impact factor: 13.501

10.  Mexiletine for symptoms and signs of myotonia in nondystrophic myotonia: a randomized controlled trial.

Authors:  Jeffrey M Statland; Brian N Bundy; Yunxia Wang; Dipa Raja Rayan; Jaya R Trivedi; Valeria A Sansone; Mohammad K Salajegheh; Shannon L Venance; Emma Ciafaloni; Emma Matthews; Giovanni Meola; Laura Herbelin; Robert C Griggs; Richard J Barohn; Michael G Hanna
Journal:  JAMA       Date:  2012-10-03       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.